MOTS-c vs Humanin
A side-by-side look at two popular peptides and how they compare.
Overview
MOTS-c and Humanin are the two most studied mitochondrial-derived peptides (MDPs), encoded within the mitochondrial genome rather than nuclear DNA. MOTS-c is primarily associated with metabolic regulation and exercise-mimetic effects, while Humanin is known for its cytoprotective and neuroprotective properties. Together they represent the fascinating field of mitochondrial retrograde signaling: how mitochondria communicate their status to the cell and the entire organism.
MOTS-c
MOTS-c is encoded in the mitochondrial 12S rRNA gene and acts as a systemic metabolic regulator. It activates AMPK, enhances insulin sensitivity, and promotes fat oxidation in ways that parallel exercise-induced metabolic adaptations. MOTS-c is commonly sought for metabolic optimization, body composition support, and cellular energy enhancement.
Humanin
Humanin, encoded in the mitochondrial 16S rRNA gene, was discovered in brain tissue that showed resilience to neurodegenerative processes. It has been associated with protection against apoptosis (programmed cell death), neuroprotection, and insulin sensitization. Humanin is commonly sought for its cytoprotective properties and potential role in supporting neural and cardiovascular health during aging.
Side-by-Side Comparison
| Category | MOTS-c | Humanin |
|---|---|---|
| Primary Focus | Metabolic regulation and exercise mimicry | Cytoprotection and neuroprotection |
| How It Works | AMPK activation, fat oxidation, insulin sensitization | Anti-apoptotic signaling via STAT3, BAX inhibition, IGFBP-3 binding |
| Gene Location | Mitochondrial 12S rRNA gene | Mitochondrial 16S rRNA gene |
| Target Systems | Skeletal muscle, adipose tissue, metabolic organs | Brain, cardiovascular system, pancreatic beta cells |
| Discovery Year | 2015 | 2001 |
| Who It's For | Those focused on metabolic health and body composition | Those focused on neuroprotection and cellular resilience |
| Commercial Availability | Increasingly available through peptide clinics and suppliers | Less commonly available; more research-focused |
Key Differences
MOTS-c's primary value lies in metabolic regulation, including insulin sensitivity and exercise-like metabolic effects. Humanin's primary value is in cytoprotection, preventing cells from undergoing stress-induced death, particularly in neural tissue. MOTS-c is more commercially accessible, while Humanin remains more research-oriented. Their biological targets are distinct despite shared mitochondrial origins.
Key Similarities
Both are mitochondrial-derived peptides that decline with age. They each improve insulin sensitivity through different mechanisms. Both represent a paradigm shift in understanding how mitochondria influence whole-body health through peptide signaling.
Which One Might Be Right for You?
MOTS-c is more appropriate for those prioritizing metabolic health, body composition, and exercise-related benefits. Humanin may interest those primarily concerned with cognitive wellness, neuroprotection, and cellular stress resilience. The choice aligns with whether metabolic or protective goals take priority. Comprehensive mitochondrial health strategies may benefit from supporting both pathways, though Humanin's limited commercial availability makes MOTS-c more practically accessible.
MOTS-c vs Humanin FAQ
For Patients
Looking for peptide therapy? Get matched with a qualified provider near you.
Related Pages
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Peptide therapies should only be administered by licensed healthcare providers. Always consult with a qualified healthcare professional before starting any new treatment. PeptideLeads is a marketing agency and does not provide medical services.